Image

Trial Comparing Loop Ileostomy Versus Loop Transverse Colostomy

Trial Comparing Loop Ileostomy Versus Loop Transverse Colostomy

Non Recruiting
18-79 years
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to determine which stoma creation technique is preferable after low anterior resection of the rectum.

Description

The investigators enroll patients with a histologically confirmed diagnosis of primary rectal cancer with or without prior chemoradiotherapy who were hospitalized at the Ufa Republican Clinical Oncology Center from February 2023 to February 2024.

All patients undergo planned laparoscopic or open low-anterior resection of the rectum with total mesorectal excision. Patients are randomized into 2 groups in a 1:1 ratio. In the first group, a loop transverse colostomy is created, and in the second group, a loop ileostomy is created. The stoma exit sites are marked in advance the day before the surgery. The bowels are prepared by mechanical means (a polyethylene glycol-based laxative with a cleansing enema) according to a standard procedure before the surgery. Standardized stoma creation techniques are used. The resected parts are collected through a separate access. Patients are followed up for 60 days after surgery.

The sample size should be 124 patients to reach statistical significance (α = 0.05, study power 80%, confidence interval (CI) = 95%.). Considering possible losses during the study, the number of patients was increased to 130.

The investigators hypothesis is that the loop ileostomy group has a 20% higher incidence of stoma dysfunction but a 20% lower incidence of SSI (stoma site infections) compared to the loop colostomy group.

Eligibility

Inclusion Criteria:

  • Histologically confirmed adenocarcinoma of the rectum (stages 1-3 according to MRI)
  • ECOG status 0-2,
  • ASA≤3.
  • At least 18 years of age
  • Written informed consent

Exclusion Criteria:

  • Emergency surgery;
  • Previously formed stoma;
  • Stage 4 disease;
  • Obstructive resection of the rectum;
  • Patients older than 79 years

Study details
    Rectal Neoplasms
    Ostomy
    Neoplasms

NCT05745909

Republican Clinical Oncological Dispensary, Ministry of Health of the Republic of Bashkortostan

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.